The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
RPT REALTY | SHBEN | 74971D101 | 5,593,764 | 435,991 | SH | DFND | 435,991 | 0 | 0 | ||
IMMUNOGEN | COM | 45253H101 | 56,793,151 | 1,915,452 | SH | DFND | 1,915,452 | 0 | 0 | ||
KARUNA THE | COM | 48576A100 | 33,803,269 | 106,800 | SH | DFND | 106,800 | 0 | 0 | ||
SPLUNK INC | COM | 848637104 | 560,727,983 | 3,680,525 | SH | DFND | 3,680,525 | 0 | 0 |